ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Women’s health firm KaNDy raises $32M for menopause study
August 30, 2018KaNDy Therapeutics now has the finances it needs to start a phase 2b trial of its nonhormonal therapy for menopausal symptoms, after raising £25 million (around $32M) in its series C. -
Statement by ResMed on United Kingdom Case with Fisher & Paykel
November 13, 2017ResMed (NYSE: RMD, ASX: RMD) today issued the following statement from David Pendarvis, the company's global general counsel and chief administrative officer:
Pharma Sources Insight January 2025
